Rabkin SD - Search Results

1

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.

Li M, Li G, Kiyokawa J, Tirmizi Z, Richardson LG, Ning J, Das S, Martuza RL, Stemmer-Rachamimov A, Rabkin SD, Wakimoto H. Li M, et al. Among authors: rabkin sd. Acta Neuropathol Commun. 2020 Dec 11;8(1):221. doi: 10.1186/s40478-020-01096-0. Acta Neuropathol Commun. 2020. PMID: 33308315 Free PMC article.

2

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1.

Yazaki T, Manz HJ, Rabkin SD, Martuza RL. Yazaki T, et al. Among authors: rabkin sd. Cancer Res. 1995 Nov 1;55(21):4752-6. Cancer Res. 1995. PMID: 7585498

3

Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant.

Mineta T, Rabkin SD, Martuza RL. Mineta T, et al. Among authors: rabkin sd. Cancer Res. 1994 Aug 1;54(15):3963-6. Cancer Res. 1994. PMID: 8033122

4

CNS tumor therapy by attenuated herpes simplex viruses.

Mineta T, Markert JM, Takamiya Y, Coen DM, Rabkin SD, Martuza RL. Mineta T, et al. Among authors: rabkin sd. Gene Ther. 1994;1 Suppl 1:S78. Gene Ther. 1994. PMID: 8542424 No abstract available.

5

Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS.

New KC, Martuza RL, Rabkin SD. New KC, et al. Among authors: rabkin sd. Gene Ther. 1994;1 Suppl 1:S79. Gene Ther. 1994. PMID: 8542425 No abstract available.

6

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.

Yazaki T, Ahmad S, Chahlavi A, Zylber-Katz E, Dean NM, Rabkin SD, Martuza RL, Glazer RI. Yazaki T, et al. Among authors: rabkin sd. Mol Pharmacol. 1996 Aug;50(2):236-42. Mol Pharmacol. 1996. PMID: 8700129

7

Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration.

Yazaki T, Martuza RL, Rabkin SD. Yazaki T, et al. Among authors: rabkin sd. Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):311-20. doi: 10.1016/s0169-328x(96)00186-6. Brain Res Mol Brain Res. 1996. PMID: 9037547 Free article.

8

Transcriptional targeting of herpes simplex virus for cell-specific replication.

Miyatake S, Iyer A, Martuza RL, Rabkin SD. Miyatake S, et al. Among authors: rabkin sd. J Virol. 1997 Jul;71(7):5124-32. doi: 10.1128/JVI.71.7.5124-5132.1997. J Virol. 1997. PMID: 9188579 Free PMC article.

9

Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma.

Miyatake S, Martuza RL, Rabkin SD. Miyatake S, et al. Among authors: rabkin sd. Cancer Gene Ther. 1997 Jul-Aug;4(4):222-8. Cancer Gene Ther. 1997. PMID: 9253507

10

In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.

Toda M, Martuza RL, Kojima H, Rabkin SD. Toda M, et al. Among authors: rabkin sd. J Immunol. 1998 May 1;160(9):4457-64. J Immunol. 1998. PMID: 9574551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters